—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Technical state

As of 2026-10-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Uptrend stack intact

Trades +10.2% vs the 50-day and +34.5% vs the 200-day average, 4.2% below the 52-week high and +112.3% off the 52-week low. Computed from daily closes.

Ranked #50 on today’s Directional Flow — Getting stronger list (scan of 2026-10-06).

The moving-average stack

Continue: the AMRX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-06

Quick answers

What is the current Closelooknet signal on AMRX?

Uptrend stack intact — Trades +10.2% vs the 50-day and +34.5% vs the 200-day average, 4.2% below the 52-week high and +112.3% off the 52-week low. Computed from daily closes. As of 2026-10-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AMRX above its 50-day and 200-day moving averages?

As of 2026-10-06, Amneal Pharmaceuticals, Inc. Class A Common Stock trades +10.2% above its 50-day and +34.5% above its 200-day average, with the 20-day +6.7% away.

How far is AMRX from its 52-week high?

4.2% below the 52-week high and 112.3% above the 52-week low, as of 2026-10-06.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.